Mycoplasma and cancer: In search of the link

Oncotarget

Volumn 2, Issue 4, 2011, Pages 271-273

  Rogers, Melissa B ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CANCER ANTIBODY; CYTOKINE; GROWTH FACTOR; PROTEIN P120;

ANTIBODY DETECTION; ARTICLE; BACTERIUM IDENTIFICATION; BIOACCUMULATION; CANCER RESEARCH; CARCINOGENESIS; DISEASE ASSOCIATION; GENE EXPRESSION; GROWTH RATE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MUTATION RATE; MYCOPLASMA; MYCOPLASMA GENITALIUM; MYCOPLASMA HOMINIS; MYCOPLASMA HYORHINIS; NONHUMAN; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; UREAPLASMA UREALYTICUM; ANIMAL; CARCINOMA; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETICS; MALE; MYCOPLASMOSIS; NEOPLASM; NOTE; ONCOGENE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ANIMALS; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MYCOPLASMA; MYCOPLASMA INFECTIONS; NEOPLASMS; ONCOGENES; PROSTATIC NEOPLASMS;

EID: 80053319855     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.264     Document Type: Article

References (30)

1. Cimolai, N, Do mycoplasmas cause human cancer? Can J Microbiol, 2001; 47: p. 691-7.
2. Waites, KB, B Katz, and RL Schelonka, Mycoplasmas and ureaplasmas as neonatal pathogens. Clin Microbiol Rev, 2005; 18: p. 757-89.
3. Waites, KB and DF Talkington, Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev, 2004; 17: p. 697-728.
4. Huang, S, JY Li, J Wu, L Meng, and CC Shou, Mycoplasma infections and different human carcinomas. World J Gastroenterol, 2001; 7: p. 266-9.
5. Pehlivan, M, G Itirli, H Onay, H Bulut, M Koyuncuoglu, and S Pehlivan, Does Mycoplasma sp. play role in small cell lung cancer? Lung Cancer, 2004; 45: p. 129-30.
6. Pehlivan, M, S Pehlivan, H Onay, M Koyuncuoglu, and Z Kirkali, Can mycoplasma-mediated oncogenesis be responsible for formation of conventional renal cell carcinoma? Urology, 2005; 65: p. 411-4.
7. Barykova, YA, DY Logunov, MM Shmarov, AZ Vinarov, DN Fiev, NA Vinarova, IV Rakovskaya, PS Baker, I Shyshynova, AJ Stephenson, EA Klein, BS Naroditsky, AL Gintsburg, and AV Gudkov, Association of Mycoplasma hominis infection with prostate cancer. Oncotarget, 2011; in press.
8. Hrbacek, J, M Urban, E Hamsikova, R Tachezy, V Eis, M Brabec, and J Heracek, Serum antibodies against genitourinary infectious agents in prostate cancer and benign prostate hyperplasia patients: a case-control study. BMC Cancer, 2011; 11: p. 53.
9. Namiki, K, S Goodison, S Porvasnik, RW Allan, KA Iczkowski, C Urbanek, L Reyes, N Sakamoto, and CJ Rosser, Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells. PLoS One, 2009; 4: p. e6872.
10. Feng, SH, S Tsai, J Rodriguez, and SC Lo, Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells. Mol Cell Biol, 1999; 19: p. 7995-8002.
11. Tsai, S, DJ Wear, JW Shih, and SC Lo, Mycoplasmas and oncogenesis: persistent infection and multistage malignant transformation. Proc Natl Acad Sci U S A, 1995; 92: p. 10197-201.
12. Jiang, S, S Zhang, J Langenfeld, SC Lo, and MB Rogers, Mycoplasma infection transforms normal lung cells and induces bone morphogenetic protein 2 expression by posttranscriptional mechanisms. J Cell Biochem, 2007; 104: p. 580-594.
13. Fogh, J and H Fogh, Chromosome Changes in Pplo-Infected Fl Human Amnion Cells. Proc Soc Exp Biol Med, 1965; 119: p. 233-8.
14. Paton, GR, JP Jacobs, and FT Perkins, Chromosome changes in human diploid-cell cultures infected with Mycoplasma. Nature, 1965; 207: p. 43-5.
15. Miller, CJ, HS Kassem, SD Pepper, Y Hey, TH Ward, and GP Margison, Mycoplasma infection significantly alters microarray gene expression profiles. Biotechniques, 2003; 35: p. 812-4.
16. Zhang, B, JW Shih, DJ Wear, S Tsai, and SC Lo, High-level expression of H-ras and c-myc oncogenes in mycoplasmamediated malignant cell transformation. Proc Soc Exp Biol Med, 1997; 214: p. 359-66.
17. Logunov, DY, DV Scheblyakov, OV Zubkova, MM Shmarov, IV Rakovskaya, KV Gurova, ND Tararova, LG Burdelya, BS Naroditsky, AL Ginzburg, and AV Gudkov, Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation. Oncogene, 2008; 27: p. 4521-31.
18. Yang, J, WC Hooper, DJ Phillips, and DF Talkington, Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun, 2002; 70: p. 3649-55.
19. Zhang, S, S Tsai, and SC Lo, Alteration of gene expression profiles during mycoplasma-induced malignant cell transformation. BMC Cancer, 2006; 6: p. 116.
20. Zhang, S, DJ Wear, and S Lo, Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells. FEMS Immunol Med Microbiol, 2000; 27: p. 43-50.
21. Yang, J, WC Hooper, DJ Phillips, and DF Talkington, Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev, 2004; 15: p. 157-68.
22. Bieniasz, M, K Oszajca, M Eusebio, J Kordiak, J Bartkowiak, and J Szemraj, The positive correlation between gene expression of the two angiogenic factors: VEGF and BMP-2 in lung cancer patients. Lung Cancer, 2009; 66: p. 319-26.
23. Langenfeld, EM, J Bojnowski, J Perone, and J Langenfeld, Expression of bone morphogenetic proteins in human lung carcinomas. Ann Thorac Surg, 2005; 80: p. 1028-32.
24. Langenfeld, EM, SE Calvano, F Abou-Nukta, SF Lowry, P Amenta, and J Langenfeld, The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis, 2003; 24: p. 1445-54.
25. Langenfeld, EM, Y Kong, and J Langenfeld, Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin. Mol Cancer Res, 2005; 3: p. 679-84.
26. Langenfeld, EM, Y Kong, and J Langenfeld, Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5. Oncogene, 2006; 25: p. 685-92.
27. Langenfeld, EM and J Langenfeld, Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res, 2004; 2: p. 141-9.
28. Feeley, BT, NQ Liu, AH Conduah, L Krenek, K Roth, WC Dougall, J Huard, S Dubinett, and JR Lieberman, Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and rank:Fc administration. J Bone Miner Res, 2006; 21: p. 1571-80.
29. Beer, DG, SL Kardia, CC Huang, TJ Giordano, AM Levin, DE Misek, L Lin, G Chen, TG Gharib, DG Thomas, ML Lizyness, R Kuick, S Hayasaka, JM Taylor, MD Iannettoni, MB Orringer, and S Hanash, Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med, 2002; 8: p. 816-24.
30. Sato, M, DS Shames, AF Gazdar, and JD Minna, A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol, 2007; 2: p. 327-43.